Do triglyceride levels increase during infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, triglyceride levels increase during infection

Triglycerides consistently rise during acute infections, with plasma levels increasing up to four-fold in septic patients, making hypertriglyceridemia a hallmark metabolic response to infection 1.

Mechanisms of Triglyceride Elevation

The increase in triglycerides during infection occurs through multiple pathways:

  • Low-dose infection/endotoxin exposure: Stimulates hepatic triglyceride production through increased de novo fatty acid synthesis and peripheral lipolysis 2
  • High-dose/severe infection: Impairs triglyceride clearance by reducing lipoprotein lipase activity and apolipoprotein E in VLDL 1, 2
  • VLDL accumulation: All sizes of VLDL particles increase during infection, particularly in severe cases 3

The severity matters algorithmically: mild infections primarily increase hepatic production, while severe sepsis adds impaired clearance, resulting in more pronounced hypertriglyceridemia 2.

Clinical Evidence Across Infection Types

This phenomenon is remarkably consistent across different pathogens:

  • Bacterial infections: Septic patients show plasma triglycerides and free fatty acids increasing up to four-fold 1
  • Viral infections: Infectious mononucleosis causes transient hypertriglyceridemia in 53.9% of patients (median 156 mg/dL vs 76 mg/dL in controls), with levels normalizing during convalescence 4
  • Parasitic infections: Trypanosoma infection produces marked hypertriglyceridemia through defective triglyceride degradation 5
  • Chronic infections: H. pylori seropositivity correlates with elevated triglycerides, particularly in females 6

Association with Inflammation and Severity

The triglyceride elevation directly correlates with:

  • Inflammatory markers (CRP, IL-6, IL-12) 3
  • Lipopolysaccharide (LPS) levels (r = 0.654, P < 0.001) 3
  • White blood cell counts and liver damage markers 4
  • Disease severity in sepsis 1, 7

Importantly, low HDL cholesterol accompanies the triglyceride rise and inversely correlates with sepsis severity 7.

Critical Pitfall: Toxic Accumulation

The most important clinical caveat: while triglyceride elevation may initially serve a protective role by binding and neutralizing bacterial endotoxins 7, inflammation simultaneously down-regulates fatty acid oxidation enzymes, leading to toxic accumulation of free fatty acids in organs, causing severe organ damage and interfering with mitochondrial function 1. This creates a dangerous metabolic trap where lipids accumulate but cannot be utilized.

Time Course

The hypertriglyceridemia is typically transient, occurring rapidly (within 2 hours of endotoxin exposure) 2 and resolving during convalescence. In infectious mononucleosis, 83.7% of patients showed decreased triglycerides during recovery 4.

Related Questions

What is the appropriate management for an 11-year-old female taking lurasidone (Latuda) 80 mg daily and lithium carbonate 450 mg twice daily who has a fasting triglyceride level of 370 mg/dL?
In a 25-year-old patient with a total cholesterol of 291 mg/dL and triglycerides of 412 mg/dL, what treatment should be initiated?
What is the appropriate management for a 37-year-old smoker with diabetes mellitus and a triglyceride level of 225 mg/dL?
What is the appropriate workup and initial management for a 38-year-old man with a two‑week history of dyspnea on exertion, hemoglobin 17.1 g/dL, platelet count 737 ×10⁹/L, and triglycerides 368 mg/dL?
For an 11-year-old female taking lurasidone (Latuda) 80 mg twice daily and lithium carbonate 450 mg twice daily who has hypertriglyceridemia, what dosing adjustments and lipid‑lowering interventions are recommended?
Which inhaled corticosteroid, budesonide or fluticasone, is preferable for asthma or COPD treatment?
Why might MRI fail to detect cysts that are identified on ultrasound?
Why is the difference between alveolar pressure and intrapleural pressure equal to transpulmonary pressure?
What is the Diamox (acetazolamide) challenge in normal-pressure hydrocephalus?
In acute urticaria, if symptoms are not adequately controlled, can the dose of a second‑generation H1 antihistamine be safely doubled on the second day?
What are the key differences between thrombotic microangiopathy (TMA) and thrombotic thrombocytopenic purpura (TTP), and how should each be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.